Replies to post #191 on Vicarious Surgical Inc (RBOT)

[RobLowe3MD_TN]

Why? What's the rationale?

Seems like at a $1-$1.2B current value, could be fairly priced - or even underpriced - given similar robotic surgery startups with solid technology and gamechanging innovation have hit the $3B+ mark (Auris, CMR).

Interesting that there is Auris DNA in this company with the Exec Chairman being the former Auris CFO. The news on JNJ/Ottava may accelerate a buyout for Vicarious.

Have you started a short position?